Redmile Group, LLC Merck & Co., Inc. Transaction History

Redmile Group, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$73.18 - $82.95 $38.4 Million - $43.5 Million	-524,300 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$70.42 - $80.13 $18.6 Million - $21.2 Million	-264,200 Reduced 33.51%	524,300 $40.5 Million
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $50 Million - $69.2 Million	788,500 New	788,500 $60.7 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.